SCHEMBL7677575

SCHEMBL7677575

CC(C)Oc1cc(C(=O)O)c2ccccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ CDC25B P30305 4/20 0.57
▸ IRAK4 Q9NWZ3 1/20 0.48
▸ NR4A1 P22736 1/20 0.47
▸ NR4A2 P43354 1/20 0.47
▸ NR4A3 Q92570 1/20 0.47
▸ MCL1 Q07820 2/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ BCL2L1 Q07817 1/20 0.42
▸ NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7674442 0.85 ALDH1A1 (0.51) ALDH1A1CDC25BIRAK4NR4A2KDM4E
SCHEMBL1162404 0.82 CDC25B (0.80) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL10889935 0.81 CDC25B (0.78) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL11551208 0.79 CDC25B (0.58) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL22129886 0.79 CDC25B (0.57) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL23156795 0.76 CDC25B (0.58) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL8035373 0.76 IRAK4 (0.60) ALDH1A1IRAK4KDM4EGLAMAPT
SCHEMBL6564013 0.75 PTPN7 (0.61) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL11158291 0.75 PDE10A (0.58) ALDH1A1CDC25BNR4A1NR4A2NR4A3
SCHEMBL31729823 0.75 DHODH (0.58) ALDH1A1CDC25BKDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403601-B1 TREATMENT OF ASTHMA, ANXIETY, DEPRESSION, EMESIS, URINARY INCONTINENCE AND RELATED CONDITIONS. ASTRAZENECA AB (SE) 2002-06-11 — — US disclosed
EP-1137637-A1 N-(2-PHENYL-4-PIPERIDINYLBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-10-04 — — EP disclosed
WO-2000034243-A1 N-(2-PHENYL-4-PIPERIDINYBUTYL)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENECARBOXAMIDES AND THEIR USE AS NEUROKININ 1 (NK1) AND/OR NEUROKININ 2 (NK2) RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-06-15 — — WO disclosed
Send feedback